NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/17/2020
Back to search
Official data from USPTO
NATIONAL BREAST CANCER RESEARCH CENTER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NATIONAL BREAST CANCER RESEARCH CENTER
ST13
US500000077625714Class
36, 42
Filing
77625714
Registration
3695054
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
04/17/2020
Trademark type
Word
Nice classes
36, 42
Filing date
12/03/2008
Registration date
10/13/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/17/2020
Last transaction
04/17/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
2003-09-00
First use in commerce
2003-09-00
Drawing code
4
Owner type
03
Owner location
Boynton Beach, FL, US
Examiner
HINES, REGINA C
Law office
M50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
The Walker Cancer Research Institute, Inc.
The Walker Cancer Research Institute, Inc.
Representatives
Lori J. Shyavitz McCarter & English, LLP
Technical classification
Nice Classes
Class 36Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Charitable fundraising services
Class 42
Medical research
Publications
History of USPTO decisions and trademark events.
32 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/17/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/17/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/16/2020
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
10/31/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/31/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
09/28/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/13/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/02/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/02/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/02/2015
E815
TEAS SECTION 8 & 15 RECEIVED
04/21/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
10/13/2009
PUBO
PUBLISHED FOR OPPOSITION
07/28/2009
NPUB
NOTICE OF PUBLICATION
07/08/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/22/2009
ALIE
ASSIGNED TO LIE
06/22/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/18/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/29/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/29/2009
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/29/2009
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/28/2009
GNFR
FINAL REFUSAL E-MAILED
05/28/2009
CNFR
FINAL REFUSAL WRITTEN
05/28/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/08/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/12/2009
GNRT
NON-FINAL ACTION E-MAILED
03/12/2009
CNRT
NON-FINAL ACTION WRITTEN
03/12/2009
DOCK
ASSIGNED TO EXAMINER
03/03/2009
NWAP
NEW APPLICATION ENTERED
12/08/2008
Continuous trademark protection
Get notified about every new filing that threatens NATIONAL BREAST CANCER RESEARCH CENTER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.